Setting the standard for Inhaled Nicotine Replacement Therapies
Liber aims to prove the safety and efficacy of inhalation-based therapies as methods of administering medicines.
Through its suite of inhaled Nicotine Replacement Therapy (iNRT) products, Liber is focused on vaporiser technology as an intervention for smoking cessation.
The
Liber
difference
01
Locally supplied and fully insured
Liber is the only Nicotine Vaping Product (NVP) manufacturer who has acquired Australian-issued product liability insurance.
02
Characterised and assessed liquids
Characterisation of all flavour compounds, subjected to comprehensive toxicological risk and hazard assessments for inhalation.
03
Domestic pharmacy distribution
Nicovape® Q is the only NVP supplied by pharmaceutical wholesalers (Symbion, Sigma and API) to over 5,500 community pharmacies nationwide.
Find us in your local pharmacy
Over 2,200 community pharmacies nationwide currently hold stock of the Nicovape® Q range in-store.
Interested in stocking Nicovape® Q?
Speak with your national wholesaler SAS representative
-
Australian Health Ministers announce unanimous support for Vaping Products Bill
Australian health ministers stand in support of a bill that will see the ban on domestic manufacture and supply, distribution, advertisement, and commercial possession of non-therapeutic vapes.
April 19, 2024 -
Campaign OBELIA seizes more than 35 tonnes of illegal vapes worth an estimated $11 million
Obelia seized more than 35 tonnes of vaping products in October, comprising 376,000 illegal vapes with a street value of more than $11 million.
November 9, 2023
Find us in your local pharmacy
Over 2,000 community pharmacies nationwide currently hold stock of the Nicovape® Q range in-store.
Interested in stocking Nicovape® Q?
Speak with your national wholesaler SAS rep